NCT04729283 (SIG-QOL) is a clinical trial of Sigmoidectomy in Sigmoid Cancer, sponsored by Nantes University Hospital.

Who is sponsoring NCT04729283?

NCT04729283 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT04729283?

Interventions in NCT04729283: Sigmoidectomy.

What condition does NCT04729283 study?

NCT04729283 studies Sigmoid Cancer, Sigmoid Diverticulosis.

Is NCT04729283 still recruiting?

NCT04729283 is currently status unknown. Last updated 29 April 2021.

Last reviewed 2021-04-29 · How we verify

NCT04729283: SIG-QOL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Quality of Life and Functionnal Resultats After Sigmodectomy Between Diverticulitis and Cancer

Status unknown Last updated 29 April 2021

What this trial tests

trial testing Sigmoidectomy in Sigmoid Cancer in 200 participants. Status unknown.

Timeline

12 April 2021

Primary endpoint
3 March 2023

3 March 2023

Quick facts

Lead sponsor	Nantes University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	12 April 2021
Primary completion	3 March 2023
Estimated completion	3 March 2023
Sites	4 locations across France

Drugs / interventions tested

Sigmoidectomy

Conditions studied

Sigmoid Cancer — all drugs for Sigmoid Cancer →
Sigmoid Diverticulosis — all drugs for Sigmoid Diverticulosis →

Sponsor

Nantes University Hospital

Who can join

Adults 18 to 99, any sex, with Sigmoid Cancer or Sigmoid Diverticulosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this present study is to compare functional results and quality of life after sigmoidectomy for diverticulitis and sigmoid cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sigmoid Cancer

Currently open trials in the same condition.

NCT07056374 — Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions · recruiting
NCT06546176 — End to End Anastomosis With Omega Suture Versus End to Anterior Rectal Wall In Colorectal Anastomosis in Sigmoid and Upp · NA · recruiting

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04729283 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 29 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04729283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing